Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Current Taxes (2016 - 2025)

Historic Current Taxes for Ani Pharmaceuticals (ANIP) over the last 12 years, with Q2 2025 value amounting to $3.3 million.

  • Ani Pharmaceuticals' Current Taxes changed N/A to $3.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.3 million, marking a year-over-year change of. This contributed to the annual value of $6.7 million for FY2024, which is 1733.22% down from last year.
  • As of Q2 2025, Ani Pharmaceuticals' Current Taxes stood at $3.3 million.
  • Ani Pharmaceuticals' Current Taxes' 5-year high stood at $14.2 million during Q1 2025, with a 5-year trough of $594000.0 in Q3 2023.
  • Its 4-year average for Current Taxes is $6.9 million, with a median of $6.7 million in 2024.
  • As far as peak fluctuations go, Ani Pharmaceuticals' Current Taxes tumbled by 7596.4% in 2021, and later surged by 2443.43% in 2025.
  • Ani Pharmaceuticals' Current Taxes (Quarter) stood at $3.7 million in 2021, then skyrocketed by 123.12% to $8.2 million in 2023, then fell by 17.33% to $6.7 million in 2024, then tumbled by 51.19% to $3.3 million in 2025.
  • Its Current Taxes was $3.3 million in Q2 2025, compared to $14.2 million in Q1 2025 and $6.7 million in Q4 2024.